Titre:
  • CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies
Auteur:Feng, William W.W.; Wilkins, Owen; Bang, Scott; Ung, Matthew; Li, Jiaqi; An, Jennifer; del Genio, Carmen; Canfield, Kaleigh; DiRenzo, James; Wells, Wendy; Gaur, Arti; Robey, Brooks R.B.; Guo, Jessie Yanxiang; Powles, Ryan Lee; Sotiriou, Christos; Pusztai, Lajos; Febbraio, Maria; Cheng, Chao; Kinlaw, William W.B.; Kurokawa, Manabu
Informations sur la publication:Cell reports, 29, 11, page (3405-3420.e5)
Statut de publication:Publié, 2019-12
Sujet CREF:Sciences de l'ingénieur
Mots-clés:AKT
drug resistance
ERK
FASN
HER2
lipid metabolism
MAPK
tyrosine kinase
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2211-1247
info:doi/10.1016/j.celrep.2019.11.008
info:pii/S2211124719314792
info:scp/85075967842
info:pmid/31825825
PMC6938262